In 2019, 29 countries in the European Union/European Economic Area (EU/EEA) reported a total of 49 752 tuberculosis (TB) cases (9.6 per 100 000 population). The overall TB notification rate in the EU/EEA continued to decline, as did most country-specific TB notification rates. However, the EU/EEA is not on track to reach the goal of ending the TB epidemic by 2030.
Multidrug resistance (MDR) was reported for 3.4% of TB cases with drug susceptibility testing results reported. Extensive drug resistance (XDR) was reported for 22.4% of MDR TB cases that underwent second-line drug susceptibility testing.
Nineteen countries reported HIV status for 78.0% of their TB cases. Of these TB cases with known HIV status, 3.1% were HIV positive.
Treatment success was achieved in 63.7% of TB cases notified in 2018, 54.9% of HIV-co-infected TB cases notified in 2018, 46.8% of MDR TB cases notified in 2017 and 34.9% of XDR TB cases notified in 2016.
Tuberculosis – Annual epidemiological report for 2019
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.